Kevin is a member of the Life Sciences Health Industry Group, practicing in the area of health care law, with a specific focus on entities regulated by the Food and Drug Administration (FDA). His practice encompasses regulatory, litigation, corporate, and contractual matters involving many health care entities, including health care providers; manufacturers of pharmaceutical drugs, biologics, and medical devices; wholesale distributors; pharmacies; and trade associations.
While Kevin counsels clients on FDA regulation, compliance, enforcement and supply chain security, his experience has also made him an important member of life sciences transaction teams. His knowledge of regulatory compliance; fraud and abuse matters; securities offerings; regulatory filings and appeals; coding, coverage, and payment issues; product development; product marketing; operational issues; clinical trials; contract negotiation; product seizures; and import/export matters, provides clients with the in-depth industry knowledge necessary when conducting due diligence.
Kevin is the deputy coordinator of the Pro Bono Committee of Reed Smith's Washington, D.C., office and is a member of the firmwide Pro Bono Committee. Kevin also frequently writes health care client alerts and contributes to various firm newsletters and blogs.